Evaluation of the utility of bone scan index (BSI) in the prediction of therapeutic effect of breast cancer patient with bone metastasis treated by zoledronic acid - Therapeutic effect evaluation of breast cancer patient with bone metastasis treated by zoledronic acid using BSI

Gunma University0 个研究点目标入组 40 人开始时间: 2013年5月20日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Patient with pregnancy, suspected pregnancy and breast feeding 2) Patient with difficulty in bone scintigraphy data analsysis due to the structural deformity or extraosseous uptake in bone scintigraphy 3) Patient with hypersensitivity to the element of zoredronic acid or bisphosphonate 4) Patient with renal dysfunction 5) Patient with active double cancer 6) Patient with severe underlying disease 7) Patient who need to be invasively treated due to infectious disorder of teeth and jawbone 8) Patient who underwent invasive dental treatment in the past three months 9) Patient who was treated by other bisphosphonate 10) Patient who was judged by medical doctor as inappropriate for this study

发起方